SEC Grants Itself Timeout From New Trading Rules
Published Date: 6/15/2026
Notice
Summary
The SEC is giving a temporary break to some new stock market rules about pricing and fees while courts review challenges. This pause affects stock exchanges and traders by delaying certain fee caps and pricing rules, helping avoid confusion or extra costs for now. The relief lasts until the court decides, so everyone gets a fair chance to adjust without rushing.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Minimum Pricing Increment Delay
The SEC delayed implementation of the amended minimum pricing increment (Rules 600(b)(89)(i)(F) and 612 of Regulation NMS) until the first business day of November 2027. National securities exchanges, national securities associations, alternative trading systems, brokers and dealers, primary listing exchanges, and applicable plan processors are temporarily exempt from complying with those rules until that date.
Access Fee Cap Compliance Extension
The SEC extended temporary exemptive relief from compliance with Rule 610(c) of Regulation NMS (the amended access fee caps) until the first business day of November 2027. Trading centers are temporarily exempt from complying with the amended access fee cap requirements through that date.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12163, The Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
The SEC wants to scrap some old rules that stop stocks from being traded at worse prices and prevent confusing market quotes. This change affects stock traders and exchanges, aiming to simplify trading and possibly speed things up. If you want to share your thoughts, you’ve got until August 17, 2026, so don’t miss out!
2026-10373, Registered Offering Reform
The SEC wants to make it easier and cheaper for more companies to sell their stocks and bonds to the public. They’re opening up special forms and benefits to more businesses, updating rules to be more modern, and cutting red tape by overriding some state rules. If you’re a company planning to raise money, these changes could speed things up and save you money, with feedback due by July 27, 2026.
2026-10222, Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
The SEC is making it easier for companies that report their finances by simplifying their categories into just two groups: big and small filers. Smaller companies, including emerging growth ones, will get more time to file reports and enjoy simpler rules, while big companies keep stricter standards. These changes aim to save time and money, with feedback open until July 20, 2026.
2026-07651, Concept Release on Consolidated Audit Trail and Other Audit Trails and Data Sources
The SEC wants your thoughts on how it tracks stock market trades using the Consolidated Audit Trail and other data tools. They’re thinking about updating rules to keep up with new tech, privacy, and security needs, and to make sure the system is fair and cost-effective. If you’re involved in the stock market or data tracking, speak up by June 22, 2026!
2026-15469, VALIC Company I and The Variable Annuity Life Insurance Company
2026-15465, Self-Regulatory Organizations; Nasdaq Texas, LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Introduce Nasdaq TotalView Plus and Nasdaq Basic Plus Data Feeds
Previous / Next Documents
Previous: 2026-11996, Government Owned Inventions Available for License: 4-Amino-2-(Piperidin-3-yl)Isoindoline-1,3-Diones as Anti-Inflammatory Agents for Systemic Degenerative and Neurodegenerative Disorders
The National Institute on Aging has created new anti-inflammatory compounds that could help treat brain and body diseases like Alzheimer's and other degenerative disorders. These new drugs are safer, work better in the body, and avoid serious side effects seen in older medicines. Researchers and companies can now license these inventions to develop new treatments, potentially speeding up cures and improving lives.
Next: 2026-11999, Center for Scientific Review; Amended Notice of Meeting
The Center for Scientific Review changed the contact person for their special meeting from Konrad J. Krzewski to John Laity. This meeting, happening June 29-30, 2026, is still closed to the public and won’t affect any funding or timing. If you were tracking this meeting, just note the new contact and keep your calendar set!